Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Snag is, Cheniere’s two export terminals are already advanced enough to generate several billion dollars in cash flow, much of which is already flowing in dividends to shareholders. Venture Global is ...

"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sabel told CNBC in an ...

Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.

More generally, markets have a way of recalibrating, and Venture Global’s IPO offers a nuanced lesson. It’s a reminder that valuations aren’t fixed by management or banker decree, but rather hammered ...

Then Wiz came along. Wiz CEO and cofounder Assaf Rappaport, hangs out in the social circle of some of their mutual ...

Venture Global, a producer of liquified natural gas, made its stock market debut on Friday as President Trump plans to boost ...

Leading fintech firm Pine Labs is gearing up to file its initial public offering (IPO) documents by mid-February. The company ...

The initial public offerings of GB Logistics Commerce, and HM Electro Mech continued to get strong response from investors ...